Position in ARVN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$134,372
-$5,548 QoQ
Shares Held
16,170
+22.5% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#124
of 198 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026VICTORY CAPITAL MANAGEMENT INC holds $2,531,634,647 across 158 Biotechnology names. ARVN ranks #122 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,173,152 | $1,079,469,792 | |
| 2 | RPRX |
Royalty Pharma plc
|
3,682,932 | $206,501,997 | |
| 3 | INCY |
Incyte Corp
|
1,480,342 | $167,811,569 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
686,719 | $165,478,677 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
253,764 | $80,212,262 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
126,343 | $78,779,914 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
172,842 | $52,030,627 | |
| 8 | BNTX |
BioNTech SE
|
539,787 | $50,227,180 |
All Filings in ARVN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $134,372 | 16,170 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $139,920 | 13,200 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $156,552 | 13,200 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $112,464 | 13,200 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $97,152 | 13,200 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $511,126 | 72,810 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $871,276 | 45,450 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $1,145,787 | 46,520 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $1,435,137 | 53,912 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $1,609,424 | 38,988 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $263,670 | 6,406 | Shares | Sole | 2024-02-05 | |
| 2022-09-30 | $425,902 | 9,573 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $406,336 | 9,654 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $562,493 | 8,358 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $988,965 | 12,040 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $1,079,269 | 13,133 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $813,043 | 10,559 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $409,291 | 6,192 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $500,747 | 5,896 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $208,665 | 8,838 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $483,344 | 14,411 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $384,703 | 9,546 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||